[andreymaltsev]

UTD по поводу длительности антикоагуляции при венозном тромбозе дает схожие рекомендации:

We suggest indefinite anticoagulation only for high-risk patients with hereditary thrombophilia (Grade 2B).

И ниже

High-risk patients*—*At present, we suggest indefinite anticoagulation only in the following high-risk patients with hereditary thrombophilia [1]:

1.Two or more spontaneous thromboses or one spontaneous thrombosis in the case of antithrombin deficiency or the antiphospholipid syndrome
2.One spontaneous life-threatening thrombosis (eg, near-fatal pulmonary embolism; cerebral, mesenteric, or portal vein thrombosis)
3.One spontaneous thrombosis at an unusual site (eg, mesenteric or cerebral vein)
4.One spontaneous thrombosis in the presence of more than a single genetic defect predisposing to a thromboembolic event (eg, combined heterozygosity for protein S deficiency, protein C deficiency, or antithrombin deficiency)